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report of three fatal cases and review of the
literature
Irene Riezzo1, Rosanna Zamparese1, Margherita Neri1, Francesco De Stefano2, Ruggero Parente1,
Cristoforo Pomara1, Emanuela Turillazzi1, Francesco Ventura2 and Vittorio Fineschi1*Abstract: Sudden death from an undiagnosed primary intracranial neoplasm is an exceptionally rare event, with
reported frequencies in the range of 0.02% to 2.1% in medico-legal autopsy series and only 12% of all cases of
sudden, unexpected death due to primary intracranial tumors are due to glioblastomas. We present three cases of
sudden, unexpected death due to glioblastoma, with different brain localization and expression. A complete
methodological forensic approach by means of autopsy, histological and immunohistochemical examinations let us
to conclude for an acute central dysregulation caused by glioblastoma and relative complication with rapid
increase of intracranial pressure as cause of death. Although modern diagnostic imaging techniques have
revolutionized the diagnosis of brain tumors, the autopsy and the careful gross examination and section of the
fixed brain (with coronal section) is still the final word in determining exact location, topography, mass effects and
histology and secondary damage of brain tumor and contributed the elucidation of the cause of death.
Immunohistochemistry and proteomic analysis are mandatory in such cases.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1218574899466985
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Glioblastoma is the most common malignant primary
brain neoplasm, representing about 12-20% of all intra-
cranial tumors and accounting for about 50-60% of all
astrocytic neoplasms [1]. The astrocytic neoplasms occur
in patients of all ages and arise at all levels of the
neuraxis. In adults, most occur in the cerebral hemi-
spheres, whereas in children typically occur in the brain
stem [2-5] or thalamus [6-9]. Less commonly affected
sites in both children and adults include the spinal cord
[10-13] and cerebellum [14-16]. The 2007 World Health
Organization (WHO) grading system designed three
lesions of diffusely infiltrating astrocytic tumors: diffuse
astrocytoma (grade II), anaplastic astrocytoma (grade III)
and glioblastoma (grade IV) [17]. Among diffusely infiltra-
tive astrocytomas of the cerebral hemispheres, a close* Correspondence: vfinesc@tin.it
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reproduction in any medium, provided the orcorrelation is observed between histologic grade and clin-
ical variables: patient age, duration of symptoms and
neurologic performance status. With occasional excep-
tions, lesions in older patients are more anaplastic, bio-
logically aggressive, recently symptomatic, and destructive
of neurologic function.
Sudden death from an undiagnosed primary intracra-
nial neoplasm is an exceptionally rare event, with
reported frequencies in the range of 0.02% to 2.1% in
medico-legal autopsy series [18-24] and only 12% of all
cases of sudden unexpected death due to primary intra-
cranial tumors are due to glioblastomas [25].
We report three cases of sudden unexpected death due
to undiagnosed glioblastoma grade IV according to WHO
[17] with different brain localization and expression.
Complete histological, immunohistochemical and prote-
omic examinations are presented, to improve diagnosis.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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First case
A 71-year-old-Caucasian man, with a past history of
hyposthenia of the right arm, cervical spine surgery,
chronic kidney disease and hepatic steatosis, showed
headache, confusion state and difficulty in walking there-
fore he was transferred to the local hospital. The neuro-
logical examination revealed poor general condition,
marked weight loss, ataxia and slowdown ideomotor, ap-
athy, fatigue, lack of initiative. The laboratory examin-
ation of blood and liquor was negative for infection/
inflammatory disease. To diagnose a multi-infarct de-
mentia the patient was scheduled for TC and magnetic
resonance imaging of the brain and the entire spine, but
suddenly died prior to the imaging examination. At aut-
opsy, moderate pulmonary edema and polyvisceral stasis
were observed. The brain weighed 1550 g and showed
massive edema. A spherical gelatinous solid mass, meas-
uring 1 cm in diameter was attached in the right me-
dulla (Figure 1). On coronal sections, the right temporal
lobe showed a reddish-rusty mass lesion, measuring
1×2 cm and the third ventricle was compressed and
dislocated. A small fragment of the mass was frozen for
Western blot.
Second case
A 79-year-old Caucasian man, with a history of ischemic
heart disease and hypertension, was brought to the Hos-
pital in the neurological unit for symptoms such as con-
fusion, slackening, sleepiness, and tremor of the upper
limbs started few days before. The brain CT scanner
examination shows a large hypodense mass in the left
temporal lobe with massive oedema and compression
phenomena on occipital and temporal lobe and midlineFigure 1 Case 1: the brain weighed 1550 g and measured cm
19×16.5×6 and showed stasis and massive edema. A spherical
gelatinous solid mass (black circle), measuring 1 cm in diameter was
attached in the right brain stem.shift. The patient was then referred for neurosurgical
consultation, but the day before surgery he suddenly
died. General autopsy performed 48hs after death was
unremarkable. The brain weighed 1600 g and measured
cm 22×16×6.5, showed diffusely swollen cerebral hemi-
spheres, an increase in volume of the left temporal lobe
(Figure 2). There was no herniation of the temporal lobe,
unci or cerebellar tonsils. On coronal section, after
fixation, the left temporal lobe showed a large mass
lesion, which measured cm 3×2.5×2.2, hemorrhagic and
surrounded by necrotic and oedematous tissue.
Third case
A 43-year-old Polish man was found dead in a slope
near the track of the railway. Death scene investigation
was unremarkable. A complete autopsy was performed
48 hs after death. The external examination revealed only
same abrasions and bruises on the face, and the upper
and lower limbs. The internal examination revealed
polyvisceral stasis, heavy lungs and reddish colored foam
on trachea and the main bronchi. The skull was entire.
The examination of the brain (cm 21×16×6, g 1630)
after fixation in buffered formalin revealed a cerebral
edema and an increase in volume of the left frontal lobe.
On coronal sections, the cerebral hemispheres were
asymmetrical with deviation of midline structures from
left toward right. In the left frontal lobe a spherical mass
(cm 3.5×3×1.5), with variegated appearance and
contained regions of necrosis and haemorrhage was
found. The blood alcohol concentration was 0.8 g/l.
Histology
In all cases, the etiopathogenetic definition was outlined
by histological examinations performed on brain tissue
samples using haematoxylin-eosin (H&E) and Perl’s andFigure 2 Case 2: on coronal section, the left temporal lobe
showed a large necrotic hemorrhagic mass lesion, which
measured cm 3×2.5×2.2, surrounded by edematous tissue.
Figure 4 Cells (arrows) within deeply eosinophilic masses
(cases 2 and 3), complex, “glomeruloid” quality of the
microvascular proliferation (arrows) (proliferating blood vessels
come to be lined by cells heaped up in disorderly fashion and
are transformed into glomeruloid or solid tufts), multinucleated
giant cells (case 1).
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and vasogenic brain edema, and in samples taken from
right medulla and temporal lobe (case I), left temporal
lobe (case II), left frontal lobe (case III) foci of central
necrosis surrounded by neoplastic cells with nuclear
pleomorphism, pseudopalisading, multinucleated cells
(“giant cells glioblastomas”) and vascular proliferation
(Figures 3, 4). Areas of extensive haemorrhage near
tumour cells were also observed.
Immunohistochemistry
The immunohistochemical examination of the brain
specimens revealed a positive reaction for antibodies
anti-GFAP (glial fibrillary acidic protein) (Figures 5, 6),
CD68, vimentin and S-100 (Figure 7). Reactions for NSE
(neuron-specific enolase), smooth muscle actin, CD34,
cytokeratins MNF (monoclonal neurofilarnent) 116,
EMA (epithelial membrane antigen), synaptophysin,
HMB45 (Human Melanoma Black) were negative. The
other organs showed signs of central dysregulation (pul-
monary oedema).
Western blot analysis
Proteomic analysis was performed using Western blot. The
positive reaction for GFAP was confirmed by Western
blotting demonstrating different bands and different
concentrations of GFAP in brain tumoural sites, compared
with positive (dementia cases) and negative control
(Figure 8).
The exitus was attributed in the second and third case
to brain oedema and massive haemorrhage into the glio-
blastoma from erosion of vessels, with an increase in
intracranial pressure and compression of cerebrospinal
fluid circulation, whereas in the first case death can beFigure 3 Samples taken from right brain stem and temporal
lobe (case I), left temporal lobe (case II), and from left frontal
lobe (case III): we observed dense cellularity, shrinking
pleomorphism, and zones of coagulative necrosis lined (white
arrow) by “palisading” tumor cells with nuclear pleomorphism.explained by distortion and compression of the medulla by
the tumour with consequent acute central dysregulation
due to glioblastoma corresponding to WHO grade IV.
Conclusions
Glioblastoma is highly malignant astrocytic glioma that ap-
pears to arise either de novo or in transition from diffuse
astrocytoma and anaplastic astrocytoma. Glioblastomas
that arise in transition from an often sizable, better-
differentiated astrocytic tumor have been referred to as
secondary glioblastomas [26]. Other glioblastomas, pri-
mary glioblastomas, are densely cellular and homoge-
neously anaplastic, and exhibit none of the less cellular andFigure 5 The immunohistochemical examination of the brain
specimens revealed a positive reaction for antibodies anti-
GFAP (glial fibrillary acidic protein). Small elongated cells and
extreme cytologic pleomorphism were evident.
Figure 6 The cells have large nucleus and a prominent
nucleolus, have a certain resemblance to the neurons, but are
GFAP +.
Figure 8 Western blot. Proteomic analysis shows the different bands
and different concentrations of GFAP in brain stem of case 1, positive
control (dementia cases) and negative control (normal brain).
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tumors. It remains a matter of debate whether these “pri-
mary” variants are truly malignant de novo or have overrun
and obscured a precursor lesion.
A med-line literature research was performed for the
period of 1993 through 2012, using the thesaurus’ terms
“sudden death” and “glioblastoma” in combination (see
Table 1) [1,20,25,27-29]. In the current literature are pub-
lished only 11 cases of sudden death due to glioblastoma
multiforme (10 men and 1 woman), age (range) 10 weeks-
75 years. In 7 cases there were no neurological symptoms
before the death and the patients were found suddenly
death [1,20,25]. In one case there was headache 2 hours
before death [30], in 1 case the man was disoriented, slow,
somnolent, five days before the death [28] and in a case ofFigure 7 Trapped reactive astrocytes were large, stellate, often
peri-vascular and intensely reactive for GFAP. The tumor cells
were weakly immunoreactive with vimentin (case 2) and S-100
(case 1).the child of 10 weeks there was irritability for one day and
large vomit before the death (Table 1) [29].
In the presented cases, the third one showed no
neurological symptoms before the death and in the
others cases there was a mild neurological symptomatol-
ogy few hours before the death.
In recent years the concept of two distinct glioblast-
oma subtypes has been developed, combining clinical,
morphological and genetic data. From this concept has
emerged a clinical/molecular distinction of “primary”
and “secondary” glioblastomas, although it is unclear
how to distinguish this differentiation, or the extent to
which it is therapeutically and prognostically relevant
[31-33]. On the whole secondary types present in youn-
ger patients, more often women who have a longer dur-
ation of symptoms, and usually lie in the cerebral
hemispheres. These tumors have a high frequency of
mutation of p53 tumor suppressor gene on chromosome
17p with accumulation of p53 protein, but infrequent
amplification of epidermal growth factor receptor
(EGFR) involved in control of cell proliferation [32-35].
Loss of chromosome 19q in the region of a presumed
tumor suppressor gene(s) as yet unidentified is more
common in secondary tumors [36].
The considerably more frequent primary form of glio-
blastoma appears more abruptly and generally later in
life than the secondary type, and more often in men.
Genetically, this variant less often has mutations of p53,
but exhibits complex genetic abnormalities including de-
letions, often homozygous, of p16. Amplification of
EGFR occurs in 30 to 40 percent of such lesions, and is
commonly associated with homozygous deletions in
p16INK4a [32,33]. Most of molecular and genetic markers are
still lacking confirmation; currently, only two markers,
O6-methylguanine-DNA methyltransferase (MGMT) promoter






1 Sutton JT et al. (2010) M 7 Right frontal lobe 7 2 hours before death complying of a headache
2 Vougiouklakis T. et al. (2006) M 34 Third ventricle, at level of the foramen of Monro 6,9 No neurological symptoms. The man was found unconscious
in bed
3 Shiferaw K. et al. (2006) M 48 Right frontal lobe 4 Patient with schizophrenia. Five day prior death, the man was
disoriented, slow, and somnolent.
4 Elgamal EA. et al. (2006) M 10 week Left parietal lobe / Irritability excessively for 1 day and large vomit
5 Matschke J. et al. (2005) F 33 Right fronto-parietal lobe / No neurological symptoms. The woman was found dead in her
apartment
6 M 52 Left cingulated gyrus with infiltration of the thalamus / No neurological symptoms. The man suddenly collapsed at
home
7 M 75 Left cerebellar hemisphere with infiltration of adjacent brainstem
structures
/ No neurological symptoms. The man was found lying dead in
his bed
8 Eberhart C.G. et al. (2001) M 39 left frontal lobe 5 No neurological symptoms. The man was found unresponsive
on the bathroom
9 M 35 Right cerebral hemisphere showed a large mass lesion, involving
the basal ganglia and internal capsule
5 No neurological symptoms. The man was found unresponsive
10 M 45 Right frontal lobe 4 The man died after his automobile left the road at a high rate
of speed and impacted a tree.
11 Matsumoto H. (1993) M 20 Left temporal lobe / /
12 Present paper M 71 Right medulla and right temporal lobe 2 Headache, confusional state and difficulty in walking few hours
before the death
13 M 79 Left temporal lobe 3 Confusion, slackening, sleepiness, and tremor of the upper
limbs start few days before the death
14 M 43 Left frontal lobe 3,5 No neurological symptoms. The man was found dead in a















Figure 9 Primary and secondary glioblastomas: distinct genetic pathways. (Modified from 39).
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tations, are commonly accepted genetic biomarkers for
patients with glioblastoma [37]. As it has been authori-
tatively stated, primary and secondary glioblastomas are
distinct disease entities and develop through distinct
genetic pathways with different mRNA and protein ex-
pression profiles. Most of these genetic alterations can
be ascribed to a determined set of functional pathways
(Figure 9). These differences may affect sensitivity to
radio- and chemotherapy and should thus be consid-
ered in the prognosis and response to therapy, but the
genetic analysis is not so relevant for forensic purposes
being fundamental, however, for this aim, the comple-
tion of diagnostic morphological investigations [38,39].
In the cases of our observation, the clinical and mor-
phological data are in agreement to the diagnosis of pri-
mary glioblastoma. In all cases, in fact, the tumor was very
aggressive and there weren't clinical symptoms before the
death. Like astrocytomas of lower grade, glioblastomas
may be discovered on evaluation for seizures or headache
but unlike lower-grade lesions whose infiltrating and in-
sinuating qualities carry the cells unobtrusively into intact
parenchyma with little resultant mass effect, at least ini-
tially, glioblastoma are often expansive and edema gener-
ating. As a result, they are more likely to produce frank
neurological deficits and sign of increased intracranial
pressure: a subset present in sudden, stroke-like fashion as
a consequence of intratumoral hemorrhage.
The features of intratumoral vascular proliferations, in
fact, have a constant correlation with the prognosis. Inglioblastoma vascular proliferation assumes two forms.
Most common is a well-known variant that forms globu-
lar masses resembling the glomerular tufts of the kidney,
this proliferation, now referred to as “microvascular pro-
liferation”. The second form of vascular hyperplasia has a
more legitimate claim to the term “endothelial prolifera-
tion” since it is intraluminal and consists largely of endothe-
lial cells within small to medium-sized vessels. Endothelial
proliferation is less common than glomeruloid microvascu-
lar proliferation and it appears to have a more constant
correlation with high-grade gliomas and a poor prognosis.
When evaluating cases of sudden death due to undiag-
nosed glioblastoma there were several problems in defining
the most probable causes of death. Although modern diag-
nostic imaging techniques have revolutionized the diagno-
sis of brain tumors, the autopsy and the careful gross
examination and section of the fixed brain (with coronal
section) is still the final word in determining exact location,
topography, mass effects and histology and secondary
damage of brain tumor and contributed the elucidation of
the cause of death [40]. Immunohistochemistry and prote-
omic analysis are mandatory in such cases [41-43].
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